| . | Clinical characteristic . |
|---|---|
| Age (year) | 56 ± 9 |
| Male/female ( n ) | 38/4 |
| Structural heart diseases ( n ) | 12 |
| Coronary artery disease | 4 |
| Hypertension | 6 |
| Non-ischaemic cardiomyopathy | 2 |
| Amiodarone use ( n ) | 14 |
| Left atrial dimension (mm) a | 43 ± 5 |
| Left ventricular ejection fraction (%) | 57 ± 8 |
| Failed pulmonary vein isolation ( n ) | 20 |
| . | Clinical characteristic . |
|---|---|
| Age (year) | 56 ± 9 |
| Male/female ( n ) | 38/4 |
| Structural heart diseases ( n ) | 12 |
| Coronary artery disease | 4 |
| Hypertension | 6 |
| Non-ischaemic cardiomyopathy | 2 |
| Amiodarone use ( n ) | 14 |
| Left atrial dimension (mm) a | 43 ± 5 |
| Left ventricular ejection fraction (%) | 57 ± 8 |
| Failed pulmonary vein isolation ( n ) | 20 |
a Measured in the left parasternal long axis view.
| . | Clinical characteristic . |
|---|---|
| Age (year) | 56 ± 9 |
| Male/female ( n ) | 38/4 |
| Structural heart diseases ( n ) | 12 |
| Coronary artery disease | 4 |
| Hypertension | 6 |
| Non-ischaemic cardiomyopathy | 2 |
| Amiodarone use ( n ) | 14 |
| Left atrial dimension (mm) a | 43 ± 5 |
| Left ventricular ejection fraction (%) | 57 ± 8 |
| Failed pulmonary vein isolation ( n ) | 20 |
| . | Clinical characteristic . |
|---|---|
| Age (year) | 56 ± 9 |
| Male/female ( n ) | 38/4 |
| Structural heart diseases ( n ) | 12 |
| Coronary artery disease | 4 |
| Hypertension | 6 |
| Non-ischaemic cardiomyopathy | 2 |
| Amiodarone use ( n ) | 14 |
| Left atrial dimension (mm) a | 43 ± 5 |
| Left ventricular ejection fraction (%) | 57 ± 8 |
| Failed pulmonary vein isolation ( n ) | 20 |
a Measured in the left parasternal long axis view.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
